Substituted oxindol derivatives and medicaments containing the same

Details for Australian Patent Application No. 2005261867 (hide)

Owner Abbott GmbH & Co.KG

Inventors Geneste, Herve; Lubisch, Wilfried; Wernet, Wolfgang; Oost, Thorsten; Hornberger, Wilfried; Unger, Liliane

Agent Spruson & Ferguson

Pub. Number AU-B-2005261867

PCT Pub. Number WO2006/005609

Priority 10 2004 033 834.5 13.07.04 DE; 60/587,407 13.07.04 US

Filing date 13 July 2005

Wipo publication date 19 January 2006

Acceptance publication date 20 November 2008

International Classifications

C07D 209/00 (2006.01) Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom

A61K 31/404 (2006.01)

A61K 31/454 (2006.01)

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

C07D 209/34 (2006.01) Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

Event Publications

1 March 2007 PCT application entered the National Phase

  PCT publication WO2006/005609 Priority application(s): WO2006/005609

20 November 2008 Application Accepted

  Published as AU-B-2005261867

19 March 2009 Standard Patent Sealed

9 February 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005261868-Use of a combination of cyclosporine and pegylated interferon for treating hepatitis C (HCV)

2005261866-3-(heteroaryl-oxy)-2-alkyl-1-aza-bicyclo alkyl derivatives as alpha.7-NACHR ligands for the treatment of CNS diseases